121 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6808

3D Global Biotech
NT$30.40-9.7%1.8%NT$2.0bn/aPS123.7xn/an/a

6610

TWi Biotechnology
NT$11.40-8.8%-45.7%NT$999.2mn/aPB6xn/an/a

4194

Holy Stone Healthcare
NT$16.85-4.0%-55.9%NT$2.1bn/aPS8.7xn/an/a

6935

Prince Pharmaceutical
NT$29.85-4.5%-35.5%NT$1.1bn/aPE70.6xn/a0.5%

6575

SyneuRx International (Taiwan)
NT$17.200%-69.6%NT$2.1bn/aPB7.7xn/an/a

6461

Intech Biopharm
NT$27.00-3.1%-22.6%NT$3.7bn/aPS143.5xn/an/a

6932

Mercury Biopharmaceutical
NT$15.60-6.3%-42.9%NT$6.5bn/aPS2421.3xn/an/a

7595

Pharmigene
NT$19.50-0.5%-14.3%NT$984.1mn/aPS7.4xn/an/a

4132

Golden Biotechnology
NT$28.55-1.7%-54.3%NT$4.1bn/aPS21.9xn/an/a

6704

Gwo Xi Stem Cell Applied Technology
NT$29.50-6.5%n/aNT$2.8bn/aPS17.6xn/an/a

6973

U-Neuron Biomedical
NT$52.40-4.0%n/aNT$1.5bn/an/an/an/a

6748

ACRO Biomedical
NT$37.35-0.1%33.4%NT$2.3bn/an/an/an/a

6892

Taiwan Bio Therapeutics
NT$36.60-4.4%-7.1%NT$1.9bn/an/an/an/a

6876

LAUNXP Biomedical
NT$28.105.2%n/aNT$904.5mn/an/an/an/a

6986

HeXun Biosciences
NT$67.10-4.8%n/aNT$3.1bn/an/an/an/a

6955

Bonraybio
NT$158.00-5.4%n/aNT$2.7bn/an/an/an/a

6917

Andros PharmaceuticalsLtd
NT$21.80-1.4%-40.6%NT$758.0mn/an/an/an/a

1295

Synbio Tech
NT$72.30-7.9%n/aNT$2.2bn/an/an/an/a

6936

Vetnostrum Animal Health
NT$36.50-0.4%0%NT$2.4bn/an/an/an/a

6939

TFBS Bioscience
NT$41.85-2.6%n/aNT$1.5bn/an/an/an/a

7607

DuoGenic StemCells
NT$32.001.3%n/aNT$977.7mn/an/an/an/a

6864

Anti-Microbial Savior BioteQ
NT$26.000.4%-24.6%NT$650.0mn/an/an/an/a

7729

Steminent Biotherapeutics
NT$33.450.6%n/aNT$1.9bn/an/an/an/a

6810

Bio Preventive Medicine
NT$36.35-2.2%-5.0%NT$1.3bn/an/an/an/a
Page 5 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.